Dutch Neuropathic Pain Filter (Patented Technology)

The Dutch Neuropathic Pain Filter is in the research and development phase as a technological concept for registering and analysing nerve signals associated with mechanisms underlying neuropathic pain. The technology focuses on exploring methods to differentiate voluntary and involuntary signal patterns within the peripheral and/or central nervous system using AI-supported data processing.

Neuropathic pain is a common clinical challenge with significant global impact on patients and healthcare systems. The Dutch Neuropathic Pain Filter is not intended for diagnosis, treatment or symptom relief; it serves exclusively as a platform for research into signal registration and signal interpretation.

Within this research framework, several technological modules are being explored, including systems for nerve-signal registration, analysis of signal variations and the investigation of algorithmic filtering techniques in a controlled experimental environment. Emphasis is placed on:

– registering different types of neural activity
– investigating technical differentiation between desired and undesired signal patterns
– exploring algorithmic filtering methods for research purposes
– adjustable signal-processing parameters, configurable by authorised researchers
– options for data readout and wireless connectivity in a secure research environment
– attention to safety considerations relating to electromagnetic fields
– integration of AI-supported analytical tools for pattern recognition and classification

The Dutch Neuropathic Pain Filter functions solely as a research platform and is not intended for clinical use or application in patients. Development activities focus on technical validation, signal analysis and exploring potential future directions in neuroscientific research.

For information or potential research collaborations, please contact us.

This website is intended exclusively for business-to-business (B2B) communication.
The information provided is aimed at professional partners, research institutions, healthcare organizations and companies involved in innovation, valorisation and technology development. It is not intended for patients or general consumer use.

Confidentiality Notice
Due to the confidential nature of our patents, inventions, and R&D activities, not all projects and development phases are publicly disclosed.

EU-office:
Coolsingel 104
3011 AG Rotterdam

info@lsbmedtech.nl